Entera Tax Provision from 2010 to 2024

ENTX Stock  USD 1.59  0.03  1.85%   
Entera Bio Tax Provision yearly trend continues to be fairly stable with very little volatility. Tax Provision is likely to outpace its year average in 2024. Tax Provision is the amount set aside by Entera Bio to cover any estimated taxes for the current period. It reflects Entera Bio's expected tax liabilities. View All Fundamentals
 
Tax Provision  
First Reported
2010-12-31
Previous Quarter
-17 K
Current Value
-16.1 K
Quarterly Volatility
40.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Tax Provision Growth Pattern

Below is the plot of the Tax Provision of Entera Bio over the last few years. It is the amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities. Entera Bio's Tax Provision historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
Tax Provision10 Years Trend
Very volatile
   Tax Provision   
       Timeline  

Entera Tax Provision Regression Statistics

Arithmetic Mean17,657
Coefficient Of Variation227.17
Mean Deviation19,349
Median20,000
Standard Deviation40,110
Sample Variance1.6B
Range196K
R-Value(0.08)
Mean Square Error1.7B
R-Squared0.01
Significance0.77
Slope(735.89)
Total Sum of Squares22.5B

Entera Tax Provision History

2024-16.1 K
2023-17 K
2022137 K
2021-59 K

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Tax Provision, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tax Provision-17 K-16.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.